Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
Hao Zhang(Chinese Academy of Sciences), San‐Qi Zhang(Xi'an Jiaotong University), Minhang Xin(Zhejiang University), Xiao-Xiao Xi(Xi'an Jiaotong University), Junjie Zhang(Chemical Synthesis Lab), Yanjie Liu(Harbin Medical University), Shuai Mao(Xi'an Jiaotong University), Axin Lu(Xi'an Jiaotong University), Hongyi Zhao(Xi'an Jiaotong University)
Cited by 120
Related Papers
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y
|European Journal of Medicinal Chemistry|2019|192
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
|European Journal of Medicinal Chemistry|2018|168
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1
|Signal Transduction and Targeted Therapy|2023|164
Strategies to target the Hedgehog signaling pathway for cancer therapy
|Medicinal Research Reviews|2018|108